Adoptivcellsterapi

Adoptivcellsterapi, which translates to adoptive cell therapy, is a type of cancer treatment that involves modifying a patient's own immune cells to better target and destroy cancer cells. This therapy leverages the power of the patient's immune system, enhancing its ability to recognize and eliminate malignant growths. The process typically begins with collecting immune cells, often T-cells, from the patient's blood or tumor. These cells are then genetically engineered in a laboratory to express specific receptors, such as chimeric antigen receptors (CARs), that are designed to bind to unique proteins found on the surface of cancer cells. Once modified, these enhanced immune cells are multiplied in large numbers and then infused back into the patient. Upon reintroduction, these "supercharged" cells actively seek out and attack cancer cells, leading to tumor regression. Adoptivcellsterapi has shown significant promise, particularly in treating certain types of blood cancers like leukemia and lymphoma, and research is ongoing to expand its application to other cancers. The effectiveness and side effect profile can vary depending on the specific type of cell therapy and the patient's condition.